Outcome measures in rheumatoid arthritis randomised trials over the last 50 years.

ABSTRACT:

Background

The development and application of standardised sets of outcomes to be measured and reported in clinical trials have the potential to increase the efficiency and value of research. One of the most notable of the current outcome sets began nearly 20 years ago: the World Health Organization and International League of Associations for Rheumatology core set of outcomes for rheumatoid arthritis clinical trials, originating from the OMERACT (Outcome Measures in Rheumatology) Initiative. This study assesses the use of this core outcome set by randomised trials in rheumatology.

Methods

An observational review was carried out of 350 randomised trials for the treatment of rheumatoid arthritis identified through The Cochrane Library (up to and including September 2012 issue

SUBMITTER: Kirkham JJ 

PROVIDER: S-EPMC3852710 | biostudies-literature | 2013 Oct

REPOSITORIES: biostudies-literature